A pilot proof of concept study of the Effects of Administration of SCFA in Rheumatoid Arthritis (EASi-RA)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Rheumatoid Arthritis
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. New diagnosis of RA
    2. Scheduled to begin treatment with methotrexate at any dose as standard medical care
    3. Able and willing to provide written informed consent prior to any study specific procedures
    4. Age 18 years and above at time of enrollment
    5. Subjects not excluded based on race or ethnicity

You may not be eligible for this study if the following are true:

    1. Participants who are pregnant or are currently breastfeeding
    2. History of sensitivity to study compound or any of their excipients
    3. Previous intolerance to SCFA or related compounds
    4. Current (within 3 months of screening) treatment with csDMARDs
    5. Current or past (ever) treatment with biologic therapies
    6. Current antibiotic treatment (within 3 months of screening)
    7. Current consumption of probiotics (within 3 months of screening)
    8. Severe hepatic impairment
    9. Renal failure
    10. History of other autoimmune disease
    11. Current immunodeficiency state

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.